© 1996 Oxford University Press
research-article |
Excision of DNA adducts of nitrogen mustards by bacterial and mammalian 3-methyladenine-DNA glycosylases
Groupe Réparation des lesions radio-et chimioinduites, CNRS URA 147, Institut Gustave-Roussy 94805 Villejuif cedex, France
1Experimental Toxicology, Ciba-Geigy, Pharmaceutical Division Summit. NJ 07901, USA
2Department of Biochemistry, College of Natural Sciences, and Yeungnam University Gyongsan, 712-749. South Korea
3To whom correspondence should be addressed
Nitrogen mustards are among the DNA alkylating agents most widely used in chemotherapy. The homogeneous Escherichia coli AlKA protein (3-methyladenine DNA glycosylase II) is shown to excise damaged guanine and adenine bases from DNA modified by mechlorethamine, uracil mustard, phenylalanine mustard and chlorambucil, and less efficiently acridine mustard adducts. Homogeneous recombinant human and rat 3-methyladenine-DNA glycosylases excise adducts formed by nitrogen mustards less efficiently than the AlKA protein. In addition to the in vitro excision of adducts, the AlKA protein eliminates cytotoxic mechlorethamine adducts from DNA in vivo.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. Episkopou, S. A. Kyrtopoulos, P. P. Sfikakis, M. Fousteri, M. A. Dimopoulos, L. H.F. Mullenders, and V. L. Souliotis Association between Transcriptional Activity, Local Chromatin Structure, and the Efficiencies of Both Subpathways of Nucleotide Excision Repair of Melphalan Adducts Cancer Res., May 15, 2009; 69(10): 4424 - 4433. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Adhikari, A. Uren, and R. Roy N-terminal Extension of N-Methylpurine DNA Glycosylase Is Required for Turnover in Hypoxanthine Excision Reaction J. Biol. Chem., October 12, 2007; 282(41): 30078 - 30084. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Gould, C. Nixon, and M. J. Tilby p53 Elevation in Relation to Levels and Cytotoxicity of Mono- and Bifunctional Melphalan-DNA Adducts Mol. Pharmacol., November 1, 2004; 66(5): 1301 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Panasci, J.-P. Paiement, G. Christodoulopoulos, A. Belenkov, A. Malapetsa, and R. Aloyz Chlorambucil Drug Resistance in Chronic Lymphocytic Leukemia: The Emerging Role of DNA Repair Clin. Cancer Res., March 1, 2001; 7(3): 454 - 461. [Abstract] [Full Text] |
||||
![]() |
A. Y. Lau, M. D. Wyatt, B. J. Glassner, L. D. Samson, and T. Ellenberger Molecular basis for discriminating between normal and damaged bases by the human alkyladenine glycosylase, AAG PNAS, December 5, 2000; 97(25): 13573 - 13578. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kamiya and H. Kasai 2-Hydroxy-dATP is incorporated opposite G by Escherichia coli DNA polymerase III resulting in high mutagenicity Nucleic Acids Res., April 1, 2000; 28(7): 1640 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saparbaev, J.-C. Mani, and J. Laval Interactions of the human, rat, Saccharomyces cerevisiae and Escherichia coli 3-methyladenine-DNA glycosylases with DNA containing dIMP residues Nucleic Acids Res., March 15, 2000; 28(6): 1332 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. D. Scharer, H. M. Nash, J. Jiricny, J. Laval, and G. L. Verdine Specific Binding of a Designed Pyrrolidine Abasic Site Analog to Multiple DNA Glycosylases J. Biol. Chem., April 10, 1998; 273(15): 8592 - 8597. [Abstract] [Full Text] [PDF] |
||||





